This course is free of charge but requires logging in to access. Don't have an account? Create an account here.Available: December 3, 2022 - December 3, 2024
Credit: 7 AMA PRA Category 1 CreditsTM, 7 Nursing Contact Hours
Ovarian cancer is the second most common gynecologic cancer in the United States and has the highest mortality rate of any gynecologic cancer. There is no simple and reliable way to screen for ovarian cancer, so it is especially important that health care practitioners help their patients recognize and discuss risk factors and warning signs.
ACOG is pleased to offer the free online course Prevention and Early Diagnosis of Ovarian Cancer, which summarizes the relevant literature and existing recommendations to guide clinicians in the equitable prevention, early diagnosis, and special considerations of ovarian cancer.
By the end of this activity, participants will be able to:
- Identify risk factors for ovarian cancer
- Summarize key health disparities in ovarian cancer
- Identify effective methods for risk modification and early diagnosis of ovarian cancer
Target AudienceObstetrician-gynecologists, nurses, nurse practitioners, physician assistants, family physicians, medical students and residents, and allied health professionals
Estimated Time to Complete7 hours
Faculty and Planner DisclosureThis project was supported by the Centers for Disease Control and Prevention of the Department of Health and Human Services under cooperative agreement number 6 NU38OT000287-04-03, which was awarded to ACOG.All authors received a one-time payment from ACOG for their participation in the development of ovarian cancer educational materials.
All authors received a one-time payment from ACOG for their participation in the development of uterine cancer educational materials.
All relevant financial relationships have been mitigated. Conflict of interest disclosure for faculty, planning committee, reviewers, and staff:
- Rebecca Brooks, MD: Speakers Bureau: AstraZeneca; Advisory Board: Tempus and GSK/Merck
- Leigha Senter-Jamieson, MD: Consultant/Speaker: AstraZeneca; Advisor: GSK
- Wenora Johnson: Patient Advocate Advisory Member: Blue Note Therapeutics and Flatron Health; Consultant: Bristol Myers Squibb
- Shilpa Shahani, MD: Consultant: Kite; Speakers Bureau: Amgen
All other faculty, planning committee members, reviewers, and staff have no conflict of interest to disclose relative to the content of the presentation.
How to Earn CreditParticipants who wish to earn AMA PRA Category 1 CreditTM must complete all sections of the course including the evaluation.
The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credit™ to be equivalent to College Cognate Credits.
This nursing continuing professional development activity was approved by the Maryland Nurses Association, which is an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCCCA).